ScholarIQanswers from OpenAlex & ORCID
Phioanh L. Nghiemphu
ResearcherPublications, citations & collaboration network
Phioanh L. Nghiemphu is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Phioanh L. Nghiemphu have?
ScholarIQindexed works
Phioanh L. Nghiemphu has 334 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Phioanh L. Nghiemphu have?
ScholarIQcitation count
Phioanh L. Nghiemphu has 12,247 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Phioanh L. Nghiemphu?
ScholarIQh-index
Phioanh L. Nghiemphu has an h-index of 57 in OpenAlex.
What is the i10-index of Phioanh L. Nghiemphu?
ScholarIQi10-index
Phioanh L. Nghiemphu has an i10-index of 127 in OpenAlex.
What is the ORCID of Phioanh L. Nghiemphu?
ScholarIQorcid
The ORCID for Phioanh L. Nghiemphu is on the source record.
What is the OpenAlex record for Phioanh L. Nghiemphu?
ScholarIQopenalex
The OpenAlex for Phioanh L. Nghiemphu is on the source record.
What are the most-cited papers on Phioanh L. Nghiemphu?
ScholarIQmost cited works
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy, Aaron Mochizuki, Joey Orpilla, Willy Hugo, Alex Lee, Tom B. Davidson, Anthony Wang, Benjamin M. Ellingson, Julie Rytlewski, Catherine Sanders, Eric S. Kawaguchi, Lin Du, Gang Li, William H. Yong, Sarah Gaffey, Adam L. Cohen, Ingo K. Mellinghoff, Eudocia Q. Lee, David A. Reardon, Barbara O’Brien, Nicholas Butowski, Phioanh L. Nghiemphu, Jennifer Clarke, Isabel Arrillaga‐Romany, Howard Colman, Thomas Kaley, John de Groot, Linda M. Liau, Patrick Y. Wen, Robert M. Prins
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu, Kevin R. Brown, Julie Dang, Shaojun Zhu, Teli Hsueh, Yinan Chen, Wei Wang, David Youngkin, Linda M. Liau, Neil A. Martin, Don Becker, Marvin Bergsneider, Albert Lai, Richard Green, Tom Oglesby, Michael Koleto, J.M. Trent, Steve Horvath, Paul S. Mischel, Ingo K. Mellinghoff, Charles L. Sawyers
Phase II Study of Bevacizumab Plus Temozolomide During and After Radiation Therapy for Patients With Newly Diagnosed Glioblastoma Multiforme
Albert Lai, Anh Tran, Phioanh L. Nghiemphu, Whitney B. Pope, Orestes E. Solis, Michael T. Selch, Emese Filka, William H. Yong, Paul S. Mischel, Linda M. Liau, Surasak Phuphanich, Keith L. Black, Scott Peak, Richard M. Green, Cynthia E. Spier, Tatjana Kolevska, Jonathan Polikoff, Louis Fehrenbacher, Robert M. Elashoff, Timothy F. Cloughesy
Evidence for Sequenced Molecular Evolution of <i>IDH1</i> Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai, Samir Kharbanda, Whitney B. Pope, Anh Tran, Orestes E. Solis, Franklin Peale, William F. Forrest, Kanan Pujara, Jose Carrillo, Ajay Pandita, Benjamin M. Ellingson, Chauncey W. Bowers, Robert Soriano, Nils Ole Schmidt, Sankar Mohan, William H. Yong, Somasekar Seshagiri, Zora Modrušan, Zhaoshi Jiang, Kenneth Aldape, Paul S. Mischel, Linda M. Liau, Cameron Escovedo, Weidong Chen, Phioanh L. Nghiemphu, C. David James, Michael D. Prados, Manfred Westphal, Katrin Lamszus, Timothy F. Cloughesy, Heidi Phillips
Epidermal Growth Factor Receptor Activation in Glioblastoma through Novel Missense Mutations in the Extracellular Domain
Jeffrey C. Lee, Igor Vivanco, Rameen Beroukhim, Julie H. Huang, Whei Feng, Ralph DeBiasi, Koji Yoshimoto, Jennifer C. King, Phioanh L. Nghiemphu, Yuki Yuza, Qing Xu, Heidi Greulich, Roman K. Thomas, J. Guillermo Paez, Timothy C. Peck, David Linhart, Karen A. Glatt, Gad Getz, Robert C. Onofrio, Liuda Ziaugra, Ross L. Levine, Stacey Gabriel, Tomohiro Kawaguchi, Keith O'Neill, Haumith Khan, Linda M. Liau, Stanley F. Nelson, P. Nagesh Rao, Paul S. Mischel, Russell O. Pieper, Tim Cloughesy, Daniel J. Leahy, William R. Sellers, Charles L. Sawyers, Matthew Meyerson, Ingo K. Mellinghoff